Literature DB >> 22697491

Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides.

Li-Xin Sun1, Zhi-Bin Lin, Xin-Suo Duan, Jie Lu, Zhi-Hua Ge, Xue-Fei Li, Xue-Jun Li, Min Li, En-Hong Xing, You-Xin Song, Jing Jia, Wei-Dong Li.   

Abstract

PURPOSE: It is obvious that malignant cells evade from immune system in patients with manifest malignancy. Deficient major histocompatibility complex (MHC) class I and costimulatory molecules on malignant cells partially consist of evasion strategy since antigen bond MHC and costimulatory molecules provide two signals necessary for T cell activation. Therefore, enhancement of MHC-I and costimulatory molecules may favor restraint of the evasion. For this purpose, Ganoderma lucidum Polysaccharides (Gl-PS) was used on B16F10 melanoma cells in this study.
METHODS: Immunocytochemistry and flowcytometry were used to determine the H-2K(b) and H-2D(b) (two prominent MHC class I molecules in C57BL mouse) as well as B7-1 and B7-2 (two prominent costimulatory molecules) expression on B16F10 cells after incubation with Gl-PS, while messenger ribonucleic acid (mRNA) of these molecules was detected by reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: The H-2K(b) and H-2D(b), and B7-1 and B7-2 on B16F10 cells and mRNAs of these molecules were enhanced by Gl-PS, and more efficient antitumor cytotoxicity was induced by the Gl-PS treated cells.
CONCLUSIONS: The MHC class I molecules and costimulatory molecules may be enhanced by Gl-PS, and more efficient immune cell mediated cytotoxicity against these B16F10 cells may be induced, which may favor cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22697491     DOI: 10.3109/1061186X.2012.697167

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  6 in total

1.  Anti-tumour effects of polysaccharides isolated from Artemisia annua L by inducing cell apoptosis and immunomodulatory anti-hepatoma effects of polysaccharides.

Authors:  Jiayu Chen; Jiaqi Chen; Xintai Wang; Chibo Liu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum.

Authors:  Li-Xin Sun; Zhi-Bin Lin; Jie Lu; Wei-Dong Li; Yan-Dong Niu; Yu Sun; Chen-Yang Hu; Guo-Qiang Zhang; Xin-Suo Duan
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 3.  Ganoderma: A Cancer Immunotherapy Review.

Authors:  Yu Cao; Xiaowei Xu; Shujing Liu; Linfang Huang; Jian Gu
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

4.  Ganoderma lucidum polysaccharides counteract inhibition on CD71 and FasL expression by culture supernatant of B16F10 cells upon lymphocyte activation.

Authors:  Li-Xin Sun; Zhi-Bin Lin; Xin-Suo Duan; Jie Lu; Zhi-Hua Ge; Min Li; En-Hong Xing; Tian-Fei Lan; Miao-Miao Jiang; Ning Yang; Wei-Dong Li
Journal:  Exp Ther Med       Date:  2013-01-29       Impact factor: 2.447

5.  Effects of T-cadherin expression on B16F10 melanoma cells.

Authors:  Xin-Suo Duan; Jie Lu; Zhi-Hua Ge; En-Hong Xing; Hai-Tao Lu; Li-Xin Sun
Journal:  Oncol Lett       Date:  2013-01-30       Impact factor: 2.967

Review 6.  Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy.

Authors:  Ye Li; Xiaomin Wang; Xiaoran Ma; Cun Liu; Jibiao Wu; Changgang Sun
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.